top of page
Search

The Science of Optimized Bone Grafting

  • 5 days ago
  • 1 min read

Advancements in tissue engineering and regenerative medicine have further improved various classes of bone grafts...

 

In the landmark publication in Periodontology 2000, Dr. Miron detailed why traditional multi-graft workflows require an evidence-based overhaul:

  • Market Usage: Over 53% of dental bone grafting procedures in North America utilize allografts, while 22% still rely on animal-derived xenografts.

Proportional use of bone-grafting materials in North America. The largest percentage (slightly over 50%) is dedicated to allografts, with approximately 15% of cases being autografts, 22% being xenografts, 5% synthetic materials, and 5% recombinant human BMP2.
Proportional use of bone-grafting materials in North America. The largest percentage (slightly over 50%) is dedicated to allografts, with approximately 15% of cases being autografts, 22% being xenografts, 5% synthetic materials, and 5% recombinant human BMP2.



  • The Biological Secret: In a Transwell migration assay evaluating cellular recruitment, mesenchymal stem cells (MSCs) migrated only toward autografts and human allografts due to native growth factors (BMP2, PDGF). Bovine xenografts and synthetics recruited virtually zero cells.


  • The NRBA Solution: By applying high-temperature sintering (300°C–1300°C) to human donor bone, Dr. Miron’s team fundamentally altered hydroxyapatite crystal kinetics so human osteoclasts cannot break it down. In a 52-week preclinical study, NRBA particles maintained long-term dimensional ridge volume identical to a xenograft, while preserving 100% human biocompatibility.




Because NRBAs are 100% human-derived, they can legally and safely be pre-packaged with standard allografts (FDBA/DFDBA) from the same donor in single, indication-specific pre-mixes.






Miron Message | Bringing the global standard of regenerative medicine into daily practice


Dr. Richard Miron

Comments

bottom of page